Beruflich Dokumente
Kultur Dokumente
http://www.battelle.org/environment/exxon-valdez.stm
Hepatitis B vaccine Anti-HIV Red blood cell enhancement Growth failure Diabetes Cancer and viral infection Neutropenia reduction Platelet enhancement
Top 10 selling biotechnology drugs from Ernst & Young LLP, Biotechnology Industry Report (2000)
www.bio.org
Cetus founded
FDA approves first recombinant DNA product, human insulin for marketing
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
Number of public companies falls for the first time Alliances among drug and biotech firms increase Legislation introduced to reform FDA Market for biotechnology stocks reaches all time high2 284 products in clinical testing or awaiting approval
FDA approves -interferon, first recominant vaccine Eli Lilly acquires Hyberitech
Trade treaty extends patent life to 20 years Product development failures keep investors away
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
www.bio.org
The patent system allows biotech companies to recover the development cost
What is a patent?
A patent is a set of exclusive rights granted by a state to a person (the patentee, usually the inventor) for a fixed period of time in exchange for the regulated, public disclosure of certain details of a device, method, process or composition of matter (substance) (known as an invention) which is new, inventive, and useful or industrially applicable. (from Wikipidea)
During the patent period, the costs of development and research may be recovered in the market.